In this study, we evaluate subcellular Skp2 expression in invasive breast carcinoma by immunohistochemistry to analyze the relationship between p-Akt1 and cytoplasmic Skp2 expression, and correlate the presence of cytoplasmic Skp2 with patient survival. Here, SKP2 is linked to invasive breast carcinoma.